𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: A potential marker in estrogen receptor-positive tumors

✍ Scribed by Larissa Wakefield; James Robinson; Hilary Long; J. Claire Ibbitt; Susanna Cooke; Helen C. Hurst; Edith Sim

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
251 KB
Volume
47
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The prognosis for patients with estrogen receptor (ER)‐positive breast cancer has improved significantly with the prescription of selective ER modulators (SERMs) for ER‐positive breast cancer treatment. However, only a proportion of ER‐positive tumors respond to SERMs, and resistance to hormonal therapies is still a major problem. Detailed analysis of published microarray studies revealed a positive correlation between overexpression of the drug metabolizing enzyme arylamine N‐acetyltransferase type 1 (NAT1) and ER positivity, and increasing evidence supports a biological role for NAT1 in breast cancer progression. We have tested a range of ER‐positive and ER‐negative breast cancer cell lines for NAT1 enzyme activity, and monitored promoter and polyadenylation site usage. Amongst ER‐positive lines, NAT1 activities ranged from 202 ± 28 nmol/min/mg cellular protein (ZR‐75‐1) to 1.8 ± 0.4 nmol/min/mg cellular protein (MCF‐7). The highest levels of NAT1 activity could not be attributed to increased NAT1 gene copy number; however, we did detect differences in NAT1 promoter and polyadenylation site usage amongst the breast tumor‐derived lines. Thus, whilst all cell lines tested accumulated transcripts derived from the proximal promoter, the line expressing NAT1 most highly additionally initiated transcripts initiating at a more distal, “tissue”‐specific promoter. These data pave the way for investigating NAT1 transcripts as candidate prognostic markers in ER‐positive breast cancer. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045‐2257/suppmat. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Estrogen regulated expression of the p21
Estrogen regulated expression of the p21Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells
✍ Soma Mandal; James R. Davie 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

## Abstract The cyclin‐dependent kinase inhibitor protein p21^Waf1/Cip1^ is a potent tumor suppressor. Here, we demonstrate that estradiol regulates the p21^Waf1/Cip1^ gene. Estradiol induces p21^Waf1/Cip1^ mRNA expression within 30–60 min independent of new protein synthesis in the estrogen recept

Expression pattern of the AP-1 family in
Expression pattern of the AP-1 family in breast cancer: Association of fosB expression with a well-differentiated, receptor-positive tumor phenotype
✍ Ana-Maria Bamberger; Carola Methner; Björn W. Lisboa; Carsten Städtler; Heinrich 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 261 KB 👁 2 views

In the present study, the expression of members of the AP-1 family of transcription factors in breast tumors (n ‫؍‬ 53) was investigated by Western blot with antibodies specific for each of the AP-1 family members (c-jun, junB, junD and c-fos, fosB, fra1 and fra2). The tumors were characterized with